These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8082307)

  • 21. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy.
    Athanassopoulos P; Vaessen LM; Balk AH; Takkenberg JJ; Maat AP; Weimar W; Bogers AJ
    Eur J Cardiothorac Surg; 2005 May; 27(5):783-9. PubMed ID: 15848314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
    van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
    Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
    [No Abstract]   [Full Text] [Related]  

  • 26. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell free serum interleukin-2 receptor levels after heart transplantation.
    McNally CM; Luckhurst E; Penny R
    J Heart Lung Transplant; 1991; 10(5 Pt 1):769-74. PubMed ID: 1958685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients.
    Pérez-Flores I; Sánchez-Fructuoso A; Santiago JL; Fernández-Arquero M; Calvo N; de la Concha EG; Barrientos A
    Transplant Proc; 2009; 41(6):2106-8. PubMed ID: 19715845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte status in endomyocardial biopsies and blood after heart transplantation.
    Schuurman HJ; Gmelig Meyling FH; Wijngaard PL; Van der Meulen A; Slootweg PJ; Jambroes G
    J Pathol; 1989 Nov; 159(3):197-203. PubMed ID: 2574232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures.
    Jutte NH; Groeneveld K; Balk AH; Ouwehand AJ; Loonen EH; Van der Linden M; Strikwerda S; Mochtar B; Claas FH; Weimar W
    Clin Exp Immunol; 1994 Oct; 98(1):158-62. PubMed ID: 7923876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients.
    Lagoo AS; George JF; Naftel DC; Griffin AK; Kirklin JK; Lagoo-Deenadayalan S; Hardy KJ; Savunen T; McGiffin DC
    J Heart Lung Transplant; 1996 Feb; 15(2):206-17. PubMed ID: 8672525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoimmunologic monitoring for the noninvasive diagnosis of cardiac rejection.
    Fieguth HG; Haverich A; Schaefers HJ; Wahlers T; Kemnitz J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2541-2. PubMed ID: 3274557
    [No Abstract]   [Full Text] [Related]  

  • 33. The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance.
    Nomura M; Plain KM; Verma N; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2006 Apr; 15(4):311-8. PubMed ID: 16635754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery.
    Tian L; Lu L; Yuan Z; Lamb JR; Tam PK
    Transplantation; 2004 Jan; 77(2):183-9. PubMed ID: 14742978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
    Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
    Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postpericardiotomy syndrome in pediatric heart transplant recipients. Immunologic characteristics.
    Cabalka AK; Rosenblatt HM; Towbin JA; Price JK; Windsor NT; Martin AB; Louis PT; Frazier OH; Bricker JT
    Tex Heart Inst J; 1995; 22(2):170-6. PubMed ID: 7647601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.
    Kobashigawa JA; Kiyosaki KK; Patel JK; Kittleson MM; Kubak BM; Davis SN; Kawano MA; Ardehali AA
    J Heart Lung Transplant; 2010 May; 29(5):504-8. PubMed ID: 20133166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and clinical allogeneic heart transplant rejection: correlations between histology and immune reactivity detected by cytokine messenger RNA.
    Normann SJ; Peck AB; Staples ED; Salomon DR; Mills RM
    J Heart Lung Transplant; 1996 Aug; 15(8):778-89. PubMed ID: 8878760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
    Carrier M; Leblanc MH; Perrault LP; White M; Doyle D; Beaudoin D; Guertin MC
    J Heart Lung Transplant; 2007 Mar; 26(3):258-63. PubMed ID: 17346628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.